Clinical Update on Metamorphopsia: Epidemiology, Diagnosis and Imaging. (2nd December 2021)

• Record Type: Journal Article
• Authors: Hanumunthadu, Daren; Lescrauwaet, Benedicte; Jaffe, Myles; Sadda, Srinivas; Wiecek, Emily; Hubschman, Jean Pierre; Patel, Praveen J.
• Is Part Of: Current eye research. Volume 46:Number 12(2021)
• Page Start: 1777
• Page End: 1791
• Publication Date: 2021-12-02
• Subjects: Optical coherence tomography -- metamorphopsia -- M-CHARTS -- preferential hyperacuity perimetry -- orientation discrimination threshold; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Ophthalmology -- Periodicals; 573.88
• DOI: 10.1080/02713683.2021.1912779
• Languages: English
• ISSNs: 0271-3683

Abstract

ABSTRACT: Purpose : To discuss the pathophysiology of metamorphopsia, its characterisation using retinal imaging and methods of assessment of patient symptoms and visual function. Methods : A literature search of electronic databases was performed Results : Metamorphopsia has commonly been associated with vitreomacular interface disorders (such as epiretinal membrane) and has also regularly been noted in diseases of the retina and choroid, particularly age-related macular degeneration and central serous chorioretinopathy. Developments in optical coherence tomography retinal imaging have enabled improved imaging of the foveal microstructure and have led to the localisation of the pathophysiology of metamorphopsia within the retinal layers of the macula. Alteration of alignment of inner and outer retinal layers at various retinal loci has been identified using multimodal imaging in patients with metamorphopsia in a range of conditions. Although the Amsler Grid assessment of metamorphopsia is a useful clinical indicator, new emerging methods of metamorphopsia assessment with psychophysical tests such as M-CHARTS and preferential hyperacuity perimetry, have been developed. Conclusions : It appears that there is a complex relationship between visual acuity and metamorphopsia symptoms that vary between retinal conditions. Although metamorphopsia has traditionally been challenging to measure in the clinic, advances in technology promise more robust, easy-to-use tests. It is possible that home assessment of metamorphopsia, particularly in conditions such as age-related macular degeneration, may help to guide the need for further clinic evaluation and consideration of treatment.